Announcements Trials
Browse Landscape

Status

Completed 138Unknown 96Recruiting 87Active not recruiting 22Terminated 18Not yet recruiting 13Withdrawn 6Enrolling by invitation 5Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 16Neoplasms 11Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 5Prostatic Neoplasms 4Lung Neoplasms 4Polycystic Ovary Syndrome 3Ovarian Neoplasms 3Glioblastoma 3Diabetes Mellitus 3Crohn Disease 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Non-alcoholic Fatty Liver Disease 2Multiple Sclerosis 2Irritable Bowel Syndrome 2Glioma 2Endometrial Neoplasms 2Dyslipidemias 2Colonic Neoplasms 2Colitis, Ulcerative 2Celiac Disease 2Carcinoma, Renal Cell 2Arthritis, Rheumatoid 2Vulvar Diseases 1Vitamin D Deficiency 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Observational × Urinary Bladder Neoplasms × Clear all
NCT05643690 2024-06-06

Urine Sample Collection for Validation of the AnchorDx UriFindâ„¢ Bladder Cancer Assay

AnchorDx Medical Co. Ltd. US

Suspended
77 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡